Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Celera Genomics (CRA) -- Ignore unavailable to you. Want to Upgrade?

To: allen menglin chen who wrote (301)	5/8/2000 7:32:00 PM
From: gao seng	Read Replies (1) \| Respond to of 746

lol at that one. I am just an investor. If you like DoubleTwist, then maybe you should look at GNSL, a recent IPO. I am thinking very hard on it. But something is fishy to me. Are they intentionally misleading> OAKLAND and PALO ALTO, Calif.--(BW HealthWire)--May 8, 2000-- DoubleTwist, Inc. and Sun Microsystems, Inc. (Nasdaq:SUNW) today announced that DoubleTwist has completed an extensive analysis of the currently available Human Genome Project data, revealing genes and other valuable information. -- They didn't complete a scientific milestone, just phase one of an internal plan. But the headline leads you to believe something else. DoubleTwist Completes the First Annotation of the Human Genome; Sun Supercomputers Used to Process All Available Sequence Data From the Human Genome Project and in another article, this: John Couch, chairman and chief executive officer of DoubleTwist, said DoubleTwist was doing this analysis, a process called annotation, and it had teamed up with Sun to make the information available on the Internet to subscribers.